<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Li Y</submitter><funding>NIAID NIH HHS</funding><funding>National Institute of Health</funding><pagination>68-74</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9974537</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>33(1)</volume><pubmed_abstract>&lt;h4>Objective&lt;/h4>We aimed to develop accurate and user-friendly genetic assays to identify the inherited neutrophil antigen-2 (HNA-2) deficiency in humans.&lt;h4>Background&lt;/h4>HNA-2 is one of the most important neutrophil antigens implicated in a number of human disorders. HNA-2 deficiency or HNA-2 null is a common phenotype observed in 3%-5% Americans. HNA-2 null individuals are at risk to produce isoantibodies (or alloantibodies) that play important roles in transfusion-related acute lung injury, immune neutropenia, and bone marrow graft failure. We previously demonstrated that the CD177 coding SNP 787A > T (c.787A > T) is the most important genetic determinant for HNA-2 deficiency. However, reliable genetic assays are not available for routine clinical laboratory application up to now.&lt;h</pubmed_abstract><journal>Transfusion medicine (Oxford, England)</journal><pubmed_title>An accurate genetic assay to identify human neutrophil antigen 2 deficiency.</pubmed_title><pmcid>PMC9974537</pmcid><funding_grant_id>R21 AI149395</funding_grant_id><funding_grant_id>R21AI149395</funding_grant_id><pubmed_authors>Wu J</pubmed_authors><pubmed_authors>Li Y</pubmed_authors><pubmed_authors>Schuller RM</pubmed_authors></additional><is_claimable>false</is_claimable><name>An accurate genetic assay to identify human neutrophil antigen 2 deficiency.</name><description>&lt;h4>Objective&lt;/h4>We aimed to develop accurate and user-friendly genetic assays to identify the inherited neutrophil antigen-2 (HNA-2) deficiency in humans.&lt;h4>Background&lt;/h4>HNA-2 is one of the most important neutrophil antigens implicated in a number of human disorders. HNA-2 deficiency or HNA-2 null is a common phenotype observed in 3%-5% Americans. HNA-2 null individuals are at risk to produce isoantibodies (or alloantibodies) that play important roles in transfusion-related acute lung injury, immune neutropenia, and bone marrow graft failure. We previously demonstrated that the CD177 coding SNP 787A > T (c.787A > T) is the most important genetic determinant for HNA-2 deficiency. However, reliable genetic assays are not available for routine clinical laboratory application up to now.&lt;h</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Feb</publication><modification>2025-04-26T11:57:18.145Z</modification><creation>2025-02-19T04:59:55.583Z</creation></dates><accession>S-EPMC9974537</accession><cross_references><pubmed>36308061</pubmed><doi>10.1111/tme.12936</doi></cross_references></HashMap>